Prostate cancer has distinct genetic properties in different groups of men that can be targeted to improve patient outcomes, ...

Prostate cancer has distinct genetic properties in different groups of men that could be targeted to improve patient outcomes, new research suggests.

Prostate cancer has distinct genetic properties in different groups of men that can be targeted to improve patient outcomes, UVA Cancer Center researchers have discovered.

A biomarker, PROSTOX, predicted late genitourinary toxicity accurately in patients with prostate cancer, yielding an area under the curve of 0.76.

Unique pathways involved in each form of GU toxicity (acute, chronic, and late) were identified in a gene ontology analysis ... the safest course of [prostate cancer] treatment to avoid ...

Haiman, ScD, professor of population and public health services and director of the Center for Genetic ... and lifestyle on prostate cancer outcomes. Nevertheless, the trends identified in this ...

McLaren, MBBS. "Building on decades of research into the genetic markers of prostate cancer, our study shows that the theory does work in practice—we can identify men at risk of aggressive cancers who ...

Dr. Bruce Montgomery, a UW Medicine oncologist, hopes that patients won't see these numbers and just throw up their hands in fear or resignation.

Dsicover a recent study that compared Stockholm3 with other established biomarkers for prostate cancer screening. Learn more.

Nearly all men with a polygenic risk score in the 90th percentile or above had a 10-year absolute risk for prostate cancer exceeding 3.8%. A polygenic risk score (PRS) identifies more patients with ...